髄膜炎菌感染症ワクチンの世界市場 2020年

• 英文タイトル：Global Meningococcal Infections Vaccine Market 2020 by Company, Regions, Type and Application, Forecast to 2025

• レポートコード：GIR201114521 • 出版社/出版日：GlobalInfoResearch / 2020年10月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール • 産業分類：医療

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本書では、髄膜炎菌感染症ワクチンの世界市場を調査対象にし、髄膜炎菌感染症ワクチンの市場概要、企業情報、企業別売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（四価（血清群A、C、W-135、Y）、二価（血清群C・Y）、血清群A、血清群B、血清群X）、用途別分析（病院、クリニック）、市場予測（2021年～2025年）情報などを整理しました。 ・市場概要 ・企業情報：Creative Biolabs(USA)、SERUM INSTITUTE OF INDIA PVT.LTD.(India) ・企業別売上、市場シェア ・髄膜炎菌感染症ワクチンの地域別市場分析 ・髄膜炎菌感染症ワクチンの北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・髄膜炎菌感染症ワクチンのヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・髄膜炎菌感染症ワクチンのアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・髄膜炎菌感染症ワクチンの南米市場規模2015-2020：ブラジル、アルゼンチンなど ・髄膜炎菌感染症ワクチンの中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・髄膜炎菌感染症ワクチンの種類別市場規模2015-2020：四価（血清群A、C、W-135、Y）、二価（血清群C・Y）、血清群A、血清群B、血清群X ・髄膜炎菌感染症ワクチンの用途別市場規模2015-2020：病院、クリニック ・髄膜炎菌感染症ワクチンの世界市場予測2021-2025：地域別、種類別、用途別 ・調査の結果・結論

Market Overview
The global Meningococcal Infections Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Meningococcal Infections Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Meningococcal Infections Vaccine market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Meningococcal Infections Vaccine market has been segmented into:
Quadrivalent (Serogroups A, C, W-135, and Y)
Bivalent (Serogroups C and Y)
Serogroup A
Serogroup B
Serogroup X

By Application, Meningococcal Infections Vaccine has been segmented into:
Hospital
Clinic

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Meningococcal Infections Vaccine market presented in the report. This section sheds light on the sales growth of different regional and country-level Meningococcal Infections Vaccine markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Meningococcal Infections Vaccine market.

The report offers in-depth assessment of the growth and other aspects of the Meningococcal Infections Vaccine market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Meningococcal Infections Vaccine Market Share Analysis
Meningococcal Infections Vaccine competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Meningococcal Infections Vaccine sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Meningococcal Infections Vaccine sales, revenue and market share for each player covered in this report.

The major players covered in Meningococcal Infections Vaccine are:
Creative Biolabs(USA)
SERUM INSTITUTE OF INDIA PVT.LTD.(India)

レポート目次

---

1 Meningococcal Infections Vaccine Market Overview
1.1 Product Overview and Scope of Meningococcal Infections Vaccine
1.2 Classification of Meningococcal Infections Vaccine by Type
1.2.1 Global Meningococcal Infections Vaccine Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Meningococcal Infections Vaccine Revenue Market Share by Type in 2019
1.2.3 Quadrivalent (Serogroups A, C, W-135, and Y)
1.2.4 Bivalent (Serogroups C and Y)
1.2.5 Serogroup A
1.2.6 Serogroup B
1.2.7 Serogroup X
1.3 Global Meningococcal Infections Vaccine Market by Application
1.3.1 Overview: Global Meningococcal Infections Vaccine Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Meningococcal Infections Vaccine Market by Regions
1.4.1 Global Meningococcal Infections Vaccine Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Meningococcal Infections Vaccine (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Meningococcal Infections Vaccine Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Meningococcal Infections Vaccine Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Meningococcal Infections Vaccine Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Meningococcal Infections Vaccine Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Meningococcal Infections Vaccine Status and Prospect (2015-2025)
2 Company Profiles
2.1 Creative Biolabs(USA)
2.1.1 Creative Biolabs(USA) Details
2.1.2 Creative Biolabs(USA) Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Creative Biolabs(USA) SWOT Analysis
2.1.4 Creative Biolabs(USA) Product and Services
2.1.5 Creative Biolabs(USA) Meningococcal Infections Vaccine Revenue, Gross Margin and Market Share (2018-2019)
2.2 SERUM INSTITUTE OF INDIA PVT.LTD.(India)
2.2.1 SERUM INSTITUTE OF INDIA PVT.LTD.(India) Details
2.2.2 SERUM INSTITUTE OF INDIA PVT.LTD.(India) Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 SERUM INSTITUTE OF INDIA PVT.LTD.(India) SWOT Analysis
2.2.4 SERUM INSTITUTE OF INDIA PVT.LTD.(India) Product and Services
2.2.5 SERUM INSTITUTE OF INDIA PVT.LTD.(India) Meningococcal Infections Vaccine Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Meningococcal Infections Vaccine Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Meningococcal Infections Vaccine Players Market Share
3.2.2 Top 10 Meningococcal Infections Vaccine Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Meningococcal Infections Vaccine Revenue and Market Share by Regions
4.2 North America Meningococcal Infections Vaccine Revenue and Growth Rate (2015-2020)
4.3 Europe Meningococcal Infections Vaccine Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Meningococcal Infections Vaccine Revenue and Growth Rate (2015-2020)
4.5 South America Meningococcal Infections Vaccine Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Meningococcal Infections Vaccine Revenue and Growth Rate (2015-2020)
5 North America Meningococcal Infections Vaccine Revenue by Countries
5.1 North America Meningococcal Infections Vaccine Revenue by Countries (2015-2020)
5.2 USA Meningococcal Infections Vaccine Revenue and Growth Rate (2015-2020)
5.3 Canada Meningococcal Infections Vaccine Revenue and Growth Rate (2015-2020)
5.4 Mexico Meningococcal Infections Vaccine Revenue and Growth Rate (2015-2020)
6 Europe Meningococcal Infections Vaccine Revenue by Countries
6.1 Europe Meningococcal Infections Vaccine Revenue by Countries (2015-2020)
6.2 Germany Meningococcal Infections Vaccine Revenue and Growth Rate (2015-2020)
6.3 UK Meningococcal Infections Vaccine Revenue and Growth Rate (2015-2020)
6.4 France Meningococcal Infections Vaccine Revenue and Growth Rate (2015-2020)
6.5 Russia Meningococcal Infections Vaccine Revenue and Growth Rate (2015-2020)
6.6 Italy Meningococcal Infections Vaccine Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Meningococcal Infections Vaccine Revenue by Countries
7.1 Asia-Pacific Meningococcal Infections Vaccine Revenue by Countries (2015-2020)
7.2 China Meningococcal Infections Vaccine Revenue and Growth Rate (2015-2020)
7.3 Japan Meningococcal Infections Vaccine Revenue and Growth Rate (2015-2020)
7.4 Korea Meningococcal Infections Vaccine Revenue and Growth Rate (2015-2020)
7.5 India Meningococcal Infections Vaccine Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Meningococcal Infections Vaccine Revenue and Growth Rate (2015-2020)
8 South America Meningococcal Infections Vaccine Revenue by Countries
8.1 South America Meningococcal Infections Vaccine Revenue by Countries (2015-2020)
8.2 Brazil Meningococcal Infections Vaccine Revenue and Growth Rate (2015-2020)
8.3 Argentina Meningococcal Infections Vaccine Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Meningococcal Infections Vaccine by Countries
9.1 Middle East & Africa Meningococcal Infections Vaccine Revenue by Countries (2015-2020)
9.2 Saudi Arabia Meningococcal Infections Vaccine Revenue and Growth Rate (2015-2020)
9.3 UAE Meningococcal Infections Vaccine Revenue and Growth Rate (2015-2020)
9.4 Egypt Meningococcal Infections Vaccine Revenue and Growth Rate (2015-2020)
9.5 South Africa Meningococcal Infections Vaccine Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Meningococcal Infections Vaccine Revenue and Market Share by Type (2015-2020)
10.2 Global Meningococcal Infections Vaccine Market Forecast by Type (2019-2024)
10.3 Quadrivalent (Serogroups A, C, W-135, and Y) Revenue Growth Rate (2015-2025)
10.4 Bivalent (Serogroups C and Y) Revenue Growth Rate (2015-2025)
10.5 Serogroup A Revenue Growth Rate (2015-2025)
10.6 Serogroup B Revenue Growth Rate (2015-2025)
10.7 Serogroup X Revenue Growth Rate (2015-2025)
11 Global Meningococcal Infections Vaccine Market Segment by Application
11.1 Global Meningococcal Infections Vaccine Revenue Market Share by Application (2015-2020)
11.2 Meningococcal Infections Vaccine Market Forecast by Application (2019-2024)
11.3 Hospital Revenue Growth (2015-2020)
11.4 Clinic Revenue Growth (2015-2020)
12 Global Meningococcal Infections Vaccine Market Size Forecast (2021-2025)
12.1 Global Meningococcal Infections Vaccine Market Size Forecast (2021-2025)
12.2 Global Meningococcal Infections Vaccine Market Forecast by Regions (2021-2025)
12.3 North America Meningococcal Infections Vaccine Revenue Market Forecast (2021-2025)
12.4 Europe Meningococcal Infections Vaccine Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Meningococcal Infections Vaccine Revenue Market Forecast (2021-2025)
12.6 South America Meningococcal Infections Vaccine Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Meningococcal Infections Vaccine Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables
Table 1. Global Meningococcal Infections Vaccine Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Meningococcal Infections Vaccine by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Meningococcal Infections Vaccine Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Meningococcal Infections Vaccine Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Creative Biolabs(USA) Corporate Information, Location and Competitors
Table 6. Creative Biolabs(USA) Meningococcal Infections Vaccine Major Business
Table 7. Creative Biolabs(USA) Meningococcal Infections Vaccine Total Revenue (USD Million) (2017-2018)
Table 8. Creative Biolabs(USA) SWOT Analysis
Table 9. Creative Biolabs(USA) Meningococcal Infections Vaccine Product and Solutions
Table 10. Creative Biolabs(USA) Meningococcal Infections Vaccine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. SERUM INSTITUTE OF INDIA PVT.LTD.(India) Corporate Information, Location and Competitors
Table 12. SERUM INSTITUTE OF INDIA PVT.LTD.(India) Meningococcal Infections Vaccine Major Business
Table 13. SERUM INSTITUTE OF INDIA PVT.LTD.(India) Meningococcal Infections Vaccine Total Revenue (USD Million) (2018-2019)
Table 14. SERUM INSTITUTE OF INDIA PVT.LTD.(India) SWOT Analysis
Table 15. SERUM INSTITUTE OF INDIA PVT.LTD.(India) Meningococcal Infections Vaccine Product and Solutions
Table 16. SERUM INSTITUTE OF INDIA PVT.LTD.(India) Meningococcal Infections Vaccine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Global Meningococcal Infections Vaccine Revenue (Million USD) by Players (2015-2020)
Table 18. Global Meningococcal Infections Vaccine Revenue Share by Players (2015-2020)
Table 19. Global Meningococcal Infections Vaccine Revenue (Million USD) by Regions (2015-2020)
Table 20. Global Meningococcal Infections Vaccine Revenue Market Share by Regions (2015-2020)
Table 21. North America Meningococcal Infections Vaccine Revenue by Countries (2015-2020)
Table 22. North America Meningococcal Infections Vaccine Revenue Market Share by Countries (2015-2020)
Table 23. Europe Meningococcal Infections Vaccine Revenue (Million USD) by Countries (2015-2020)
Table 24. Asia-Pacific Meningococcal Infections Vaccine Revenue (Million USD) by Countries (2015-2020)
Table 25. South America Meningococcal Infections Vaccine Revenue by Countries (2015-2020)
Table 26. South America Meningococcal Infections Vaccine Revenue Market Share by Countries (2015-2020)
Table 27. Middle East and Africa Meningococcal Infections Vaccine Revenue (Million USD) by Countries (2015-2020)
Table 28. Middle East and Africa Meningococcal Infections Vaccine Revenue Market Share by Countries (2015-2020)
Table 29. Global Meningococcal Infections Vaccine Revenue (Million USD) by Type (2015-2020)
Table 30. Global Meningococcal Infections Vaccine Revenue Share by Type (2015-2020)
Table 31. Global Meningococcal Infections Vaccine Revenue Forecast by Type (2021-2025)
Table 32. Global Meningococcal Infections Vaccine Revenue by Application (2015-2020)
Table 33. Global Meningococcal Infections Vaccine Revenue Share by Application (2015-2020)
Table 34. Global Meningococcal Infections Vaccine Revenue Forecast by Application (2021-2025)
Table 35. Global Meningococcal Infections Vaccine Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Meningococcal Infections Vaccine Picture
Figure 2. Global Meningococcal Infections Vaccine Revenue Market Share by Type in 2019
Figure 3. Quadrivalent (Serogroups A, C, W-135, and Y) Picture
Figure 4. Bivalent (Serogroups C and Y) Picture
Figure 5. Serogroup A Picture
Figure 6. Serogroup B Picture
Figure 7. Serogroup X Picture
Figure 8. Meningococcal Infections Vaccine Revenue Market Share by Application in 2019
Figure 9. Hospital Picture
Figure 10. Clinic Picture
Figure 11. Global Meningococcal Infections Vaccine Revenue (USD Million) and Growth Rate (2015-2025)
Figure 12. North America Meningococcal Infections Vaccine Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Europe Meningococcal Infections Vaccine Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Asia-Pacific Meningococcal Infections Vaccine Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. South America Meningococcal Infections Vaccine Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Middle East and Africa Meningococcal Infections Vaccine Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Meningococcal Infections Vaccine Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Meningococcal Infections Vaccine Revenue Share by Players in 2019
Figure 19. Global Top 5 Players Meningococcal Infections Vaccine Revenue Market Share in 2019
Figure 20. Global Top 10 Players Meningococcal Infections Vaccine Revenue Market Share in 2019
Figure 21. Key Players Market Share Trend
Figure 22. Global Meningococcal Infections Vaccine Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 23. Global Meningococcal Infections Vaccine Revenue Market Share by Regions (2015-2020)
Figure 24. Global Meningococcal Infections Vaccine Revenue Market Share by Regions in 2018
Figure 25. North America Meningococcal Infections Vaccine Revenue and Growth Rate (2015-2020)
Figure 26. Europe Meningococcal Infections Vaccine Revenue and Growth Rate (2015-2020)
Figure 27. Asia-Pacific Meningococcal Infections Vaccine Revenue and Growth Rate (2015-2020)
Figure 28. South America Meningococcal Infections Vaccine Revenue and Growth Rate (2015-2020)
Figure 29. Middle East and Africa Meningococcal Infections Vaccine Revenue and Growth Rate (2015-2020)
Figure 30. North America Meningococcal Infections Vaccine Revenue Market Share by Countries (2015-2020)
Figure 31. North America Meningococcal Infections Vaccine Revenue Market Share by Countries in 2019
Figure 32. USA Meningococcal Infections Vaccine Revenue and Growth Rate (2015-2020)
Figure 33. Canada Meningococcal Infections Vaccine Revenue and Growth Rate (2015-2020)
Figure 34. Mexico Meningococcal Infections Vaccine Revenue and Growth Rate (2015-2020)
Figure 35. Europe Meningococcal Infections Vaccine Revenue Market Share by Countries (2015-2020)
Figure 36. Europe Meningococcal Infections Vaccine Revenue Market Share by Countries in 2019
Figure 37. Germany Meningococcal Infections Vaccine Revenue and Growth Rate (2015-2020)
Figure 38. UK Meningococcal Infections Vaccine Revenue and Growth Rate (2015-2020)
Figure 39. France Meningococcal Infections Vaccine Revenue and Growth Rate (2015-2020)
Figure 40. Russia Meningococcal Infections Vaccine Revenue and Growth Rate (2015-2020)
Figure 41. Italy Meningococcal Infections Vaccine Revenue and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Meningococcal Infections Vaccine Revenue Market Share by Countries (2015-2020)
Figure 43. Asia-Pacific Meningococcal Infections Vaccine Revenue Market Share by Countries in 2019
Figure 44. China Meningococcal Infections Vaccine Revenue and Growth Rate (2015-2020)
Figure 45. Japan Meningococcal Infections Vaccine Revenue and Growth Rate (2015-2020)
Figure 46. Korea Meningococcal Infections Vaccine Revenue and Growth Rate (2015-2020)
Figure 47. India Meningococcal Infections Vaccine Revenue and Growth Rate (2015-2020)
Figure 48. Southeast Asia Meningococcal Infections Vaccine Revenue and Growth Rate (2015-2020)
Figure 49. South America Meningococcal Infections Vaccine Revenue Market Share by Countries (2015-2020)
Figure 50. South America Meningococcal Infections Vaccine Revenue Market Share by Countries in 2019
Figure 51. Brazil Meningococcal Infections Vaccine Revenue and Growth Rate (2015-2020)
Figure 52. Argentina Meningococcal Infections Vaccine Revenue and Growth Rate (2015-2020)
Figure 53. Middle East and Africa Meningococcal Infections Vaccine Revenue Market Share by Countries (2015-2020)
Figure 54. Middle East and Africa Meningococcal Infections Vaccine Revenue Market Share by Countries in 2019
Figure 55. Saudi Arabia Meningococcal Infections Vaccine Revenue and Growth Rate (2015-2020)
Figure 56. UAE Meningococcal Infections Vaccine Revenue and Growth Rate (2015-2020)
Figure 57. Egypt Meningococcal Infections Vaccine Revenue and Growth Rate (2015-2020)
Figure 58. South Africa Meningococcal Infections Vaccine Revenue and Growth Rate (2015-2020)
Figure 59. Global Meningococcal Infections Vaccine Revenue Share by Type (2015-2020)
Figure 60. Global Meningococcal Infections Vaccine Revenue Share by Type in 2019
Figure 61. Global Meningococcal Infections Vaccine Market Share Forecast by Type (2021-2025)
Figure 62. Global Quadrivalent (Serogroups A, C, W-135, and Y) Revenue Growth Rate (2015-2020)
Figure 63. Global Bivalent (Serogroups C and Y) Revenue Growth Rate (2015-2020)
Figure 64. Global Serogroup A Revenue Growth Rate (2015-2020)
Figure 65. Global Serogroup B Revenue Growth Rate (2015-2020)
Figure 66. Global Serogroup X Revenue Growth Rate (2015-2020)
Figure 67. Global Meningococcal Infections Vaccine Revenue Share by Application (2015-2020)
Figure 68. Global Meningococcal Infections Vaccine Revenue Share by Application in 2019
Figure 69. Global Meningococcal Infections Vaccine Market Share Forecast by Application (2021-2025)
Figure 70. Global Hospital Revenue Growth Rate (2015-2020)
Figure 71. Global Clinic Revenue Growth Rate (2015-2020)
Figure 72. Global Meningococcal Infections Vaccine Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 73. Global Meningococcal Infections Vaccine Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 74. Global Meningococcal Infections Vaccine Revenue Market Share Forecast by Regions (2021-2025)
Figure 75. North America Meningococcal Infections Vaccine Revenue Market Forecast (2021-2025)
Figure 76. Europe Meningococcal Infections Vaccine Revenue Market Forecast (2021-2025)
Figure 77. Asia-Pacific Meningococcal Infections Vaccine Revenue Market Forecast (2021-2025)
Figure 78. South America Meningococcal Infections Vaccine Revenue Market Forecast (2021-2025)
Figure 79. Middle East and Africa Meningococcal Infections Vaccine Revenue Market Forecast (2021-2025)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel

---